EU on a Mission to Boost R&D.

The article discusses the move of the European Union (EU) to offer scientific advice to pharmaceutical companies on major efficacy, safety, and quality issues to encourage drug development. The pharmaceutical trade and professional associations mentions the need for more advice on production processes and chemistry, manufacturing, and controls (CMC) for the development. The launch of PRIority MEdicines (PRIME) scientific advisory scheme by the European Medicines Agency (EMA) is also tackled.